PMID- 15051635 OWN - NLM STAT- MEDLINE DCOM- 20040920 LR - 20210514 IS - 1524-4539 (Electronic) IS - 0009-7322 (Linking) VI - 109 IP - 16 DP - 2004 Apr 27 TI - Conformational rearrangement in C-reactive protein is required for proinflammatory actions on human endothelial cells. PG - 2016-22 AB - BACKGROUND: C-reactive protein (CRP) has been suggested to actively amplify the inflammatory response underlying coronary heart diseases by directly activating endothelial cells. In this study, we investigated whether loss of the cyclic pentameric structure of CRP, resulting in formation of modified or monomeric CRP (mCRP), is a prerequisite for endothelial cell activation. METHODS AND RESULTS: We examined the impact of native CRP and mCRP on the production of monocyte chemoattractant protein-1 (MCP-1) and interleukin-8 (IL-8), key regulators of leukocyte recruitment, and on the expression of intercellular adhesion molecule-1 (ICAM-1), E-selectin, and vascular adhesion molecule-1 (VCAM-1) in human cultured coronary artery endothelial cells (HCAECs). Incubation with mCRP for 4 hours increased MCP-1 and IL-8 secretion and mRNA levels and expression of ICAM-1, E-selectin, and VCAM-1 protein and mRNA. Significant induction occurred at 1 to 5 microg/mL, reached a maximum at 30 microg/mL, and did not require the presence of serum. Native CRP was without detectable effects at 4 hours, whereas it enhanced cytokine release after a 24-hour incubation. An anti-FcgammaRIII (CD16) but not an anti-FcgammaRII (CD32) antibody produced a 14% to 32% reduction of the mCRP effects (P<0.05). mCRP but not CRP evoked phosphorylation of p38 mitogen-activated protein kinase, and inhibition of this kinase with SB 203580 reversed the effects of mCRP. Furthermore, culture of HCAECs in the presence of SB203580 markedly decreased mCRP-stimulated E-selectin and ICAM-1-dependent adhesion of neutrophils to HCAECs (P<0.001). CONCLUSIONS: Loss of pentameric symmetry in CRP, resulting in formation of mCRP, promotes a proinflammatory HCAEC phenotype through a p38 MAPK-dependent mechanism. FAU - Khreiss, Tarek AU - Khreiss T AD - Research Center, Maisonneuve-Rosemont Hospital and Department of Medicine , University of Montreal, Montreal, QC, Canada. FAU - Jozsef, Levente AU - Jozsef L FAU - Potempa, Lawrence A AU - Potempa LA FAU - Filep, Janos G AU - Filep JG LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20040329 PL - United States TA - Circulation JT - Circulation JID - 0147763 RN - 0 (CRP protein, human) RN - 0 (Cell Adhesion Molecules) RN - 0 (Chemokine CCL2) RN - 0 (Interleukin-8) RN - 0 (Receptors, Immunologic) RN - 9007-41-4 (C-Reactive Protein) RN - EC 2.7.11.24 (Mitogen-Activated Protein Kinases) RN - EC 2.7.11.24 (p38 Mitogen-Activated Protein Kinases) SB - IM CIN - Circulation. 2004 Apr 27;109(16):1914-7. PMID: 15117860 MH - C-Reactive Protein/*chemistry/pharmacology MH - Cell Adhesion MH - Cell Adhesion Molecules/biosynthesis MH - Chemokine CCL2/metabolism MH - Coronary Vessels/cytology MH - Endothelium, Vascular/chemistry/cytology/*immunology MH - Humans MH - Inflammation/immunology MH - Interleukin-8/metabolism MH - Mitogen-Activated Protein Kinases/metabolism MH - Neutrophils/immunology MH - Protein Conformation MH - Receptors, Immunologic/analysis MH - p38 Mitogen-Activated Protein Kinases EDAT- 2004/03/31 05:00 MHDA- 2004/09/21 05:00 CRDT- 2004/03/31 05:00 PHST- 2004/03/31 05:00 [pubmed] PHST- 2004/09/21 05:00 [medline] PHST- 2004/03/31 05:00 [entrez] AID - 01.CIR.0000125527.41598.68 [pii] AID - 10.1161/01.CIR.0000125527.41598.68 [doi] PST - ppublish SO - Circulation. 2004 Apr 27;109(16):2016-22. doi: 10.1161/01.CIR.0000125527.41598.68. Epub 2004 Mar 29.